arrow
P

Philip S. Insel

university of california
H指数:50
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tau positron emission tomography harmonization using the CenTauR approach: General conversion equations, relevant cut‐points, and external validation

使用CenTauR方法进行Tau正电子发射断层扫描标准化:通用转换方程、相关截断点及外部验证

2026-10-300
OA
Depression severity and sleep efficiency's associations with amyloid burden are additive but dependent on underlying genetic risk in late life depression

抑郁症严重程度和睡眠效率与淀粉样蛋白负荷的关联是累加的,但取决于晚发性抑郁症的潜在遗传风险

2026-10-090
OAAI
Accelerated cognitive decline in late life depression: The role of Amyloid-β, cortico-limbic volume, and white matter hyperintensities

老年期抑郁症中认知加速衰退:Amyloid-β、皮质-边缘体积和脱髓鞘高信号的作用

2025-08-290
PRE
Cortico-limbic volume abnormalities in late life depression are distinct from β amyloid and white matter pathologies

晚年抑郁症中的皮质边缘体积异常与 β 淀粉样蛋白和白质病理不同

2024-11-070
PRE
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
2024-07-231
OA
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings

记忆诊所环境中萎缩异质性和进展的可推广数据驱动模型

BRAIN
IF11.7
2024-04-241
OAAI
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis

[18F]flortaucipir,[18F]RO948和 [18F]MK6240 tau PET示踪剂的多中心比较,以检测鉴别诊断疾病的共同目标ROI

2021-05-2755
OAAI
Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging
2021-04-1918
OAAI